Brandon M. Wagner

Free fatty acid receptor 4 responds to endogenous fatty acids to protect the heart from pressure overload.

C. D. Wright, T. O’Connell, Q. Wells, 2021, Cardiovascular research.

Guanylyl cyclase‐A phosphorylation decreases cardiac hypertrophy and improves systolic function in male, but not female, mice

T. O’Connell, J. Osborn, Chastity L. Healy, 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Prevention of guanylyl cyclase–B dephosphorylation rescues achondroplastic dwarfism

Yi-Ching Lee, N. Kaci, L. Legeai-Mallet, 2021, JCI insight.

Male mice with elevated C-type natriuretic peptide-dependent guanylyl cyclase-B activity have increased osteoblasts, bone mass and bone strength.

S. Khosla, L. Suva, D. Gaddy, 2020, Bone.

Epitope-tagged and phosphomimetic mouse models for investigating natriuretic peptide-stimulated receptor guanylyl cyclases

T. O’Connell, L. Jaffe, T. Uliasz, 2022, Frontiers in Molecular Neuroscience.

Guanylyl Cyclase-B Dependent Bone Formation in Mice is Associated with Youth, Increased Osteoblasts, and Decreased Osteoclasts

S. Khosla, L. Suva, D. Gaddy, 2022, Calcified Tissue International.

Free fatty acid receptor 4 (FFAR4) regulates cardiac oxylipin balance to promote inflammation resolution in a model of heart failure preserved ejection fraction secondary to metabolic syndrome

T. O’Connell, G. Shearer, K. Murphy, 2022, bioRxiv.

FFAR4 regulates cardiac oxylipin balance to promote inflammation resolution in HFpEF secondary to metabolic syndrome

T. O’Connell, G. Shearer, K. Murphy, 2023, Journal of lipid research.

Free fatty acid receptor 4 is a nutrient sensor that resolves inflammation to maintain cardiac homeostasis

C. D. Wright, T. O’Connell, B. Jensen, 2019, bioRxiv.